Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
CJC-1295 with DAC CJC-1295 DAC is most relevant when researchers want to study: Prolonged GHRH receptor activation Sustained GH and IGF-1 elevation Long-duration GH-axis stimulation Albumin-binding peptide pharmacology Extended half-life peptide design The original clinical studies focused on pharmacokinetics, pharmacodynamics, GH/IGF-1 response, and tolerability in healthy adults. CJC-1295 No DAC / Modified GRF (1-29) No DAC is more relevant when researchers want to study: Shorter GHRH-like signaling Pulsatile GH release GH-axis responsiveness Interaction with GH secretagogues Short-acting GHRH analog behavior This makes No DAC conceptually closer to sermorelin-style research, though it is structurally modified for greater stability than native GHRH fragments
Effect of bone morphogenetic protein-2 on proliferation and apoptosis of gastric cancer cells
no claim of therapeutic efficacy is made or implied
For researchers seeking comprehensive regenerative support, combining both peptides addresses a broader range of tissue types and repair mechanisms than either alone
These side effects have usually disappeared in a few days or weeks
Retractions send a clear message that the validity of the paper has been brought into question
US$ 26.97
US$ 27.40
US$ 22.10
US$ 27.73
US$ 21.59
US$ 23.66
US$ 24.20
